Literature DB >> 17150238

Degradation of the encephalomyocarditis virus and hepatitis A virus 3C proteases by the ubiquitin/26S proteasome system in vivo.

Peter E Schlax1, Jin Zhang, Elizabeth Lewis, Antonio Planchart, T Glen Lawson.   

Abstract

We have isolated stably transfected mouse embryonic fibroblast cell lines that inducibly express either the mature encephalomyocarditis virus (EMCV) or hepatitis A virus (HAV) 3C protease and have used these cells to demonstrate that both proteins are subject to degradation in vivo by the ubiquitin/26S proteasome system. The detection of 3C protease expression in these cells requires inducing conditions and the presence of one of several proteasome inhibitors. Both 3C proteases are incorporated into conjugates with ubiquitin in vivo. HAV 3C protease expression has deleterious effects on cell viability, as determined by observation and counting of cells cultured in the absence or presence of inducing conditions. The EMCV 3C protease was found to be preferentially localized to the nucleus of induced cells, while the HAV 3C protease remains in the cytoplasm. The absence of polyubiquitinated EMCV 3C protease conjugates in nuclear fraction preparations suggests that localization to the nucleus can protect this protein from ubiquitination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17150238     DOI: 10.1016/j.virol.2006.10.043

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  SUMOylation promotes PML degradation during encephalomyocarditis virus infection.

Authors:  Bouchra El McHichi; Tarik Regad; Mohamed-Ali Maroui; Manuel S Rodriguez; Aleksey Aminev; Sylvie Gerbaud; Nicolas Escriou; Laurent Dianoux; Mounira K Chelbi-Alix
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

2.  Theiler's murine encephalomyelitis virus leader protein is the only nonstructural protein tested that induces apoptosis when transfected into mammalian cells.

Authors:  Jilao Fan; Kyung-No Son; Sevim Yildiz Arslan; Zhiguo Liang; Howard L Lipton
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

3.  Site-specific cleavage of the host poly(A) binding protein by the encephalomyocarditis virus 3C proteinase stimulates viral replication.

Authors:  Mariko Kobayashi; Carolina Arias; Alexandra Garabedian; Ann C Palmenberg; Ian Mohr
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

4.  E6AP/UBE3A catalyzes encephalomyocarditis virus 3C protease polyubiquitylation and promotes its concentration reduction in virus-infected cells.

Authors:  Marybeth Carmody; Tara P Notarianni; Larissa A Sambel; Shannon J Walsh; Jenna M Burke; Jenna L Armstrong; T Glen Lawson
Journal:  Biochem Biophys Res Commun       Date:  2017-10-18       Impact factor: 3.575

Review 5.  The encephalomyocarditis virus.

Authors:  Margot Carocci; Labib Bakkali-Kassimi
Journal:  Virulence       Date:  2012-06-22       Impact factor: 5.882

6.  PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection.

Authors:  Yong Zhang; Dailing Mao; William T Roswit; Xiaohua Jin; Anand C Patel; Dhara A Patel; Eugene Agapov; Zhepeng Wang; Rose M Tidwell; Jeffrey J Atkinson; Guangming Huang; Ronald McCarthy; Jinsheng Yu; Nadezhda E Yun; Slobodan Paessler; T Glen Lawson; Natalie S Omattage; Tom J Brett; Michael J Holtzman
Journal:  Nat Immunol       Date:  2015-10-19       Impact factor: 25.606

Review 7.  Broad-spectrum antiviral agents.

Authors:  Jun-Da Zhu; Wen Meng; Xiao-Jia Wang; Hwa-Chain R Wang
Journal:  Front Microbiol       Date:  2015-05-22       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.